✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals

Transgene Biotek Ltd.

TRABI

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹23 Cr.
P/E
0.00

Transgene Biotek Ltd.

  • Transgene Biotek
  • Family Care Hospital
  • KK Shah Hospitals

FAQs on Transgene Biotek Ltd. Shareprice

Transgene Biotek has given lower returns compared to its competitors.
Transgene Biotek has grown at ~-40.56% over the last 2yrs while peers have grown at a median rate of -29.21%

There is insufficient historical data to gauge this.
Latest PE of Transgene Biotek is 0

View FAQ's On Business

Growth Table

  • Transgene Biotek Ltd.
  • Family Care Hospital
  • KK Shah Hospitals

Balance Sheet

  • Transgene Biotek Ltd.
  • Family Care Hospital
  • KK Shah Hospitals

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Transgene Biotek Ltd.
  • Family Care Hospital
  • KK Shah Hospitals

Cash Flow

  • Transgene Biotek Ltd.
  • Family Care Hospital
  • KK Shah Hospitals

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Transgene Biotek Ltd.
  • Family Care Hospital
  • KK Shah Hospitals

Quarterly Results

  • Transgene Biotek Ltd.
  • Family Care Hospital
  • KK Shah Hospitals

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Transgene Biotek Ltd. Financials

Transgene Biotek balance sheet is weak and might have solvency issues

Yes, The net debt of Transgene Biotek is increasing.
Latest net debt of Transgene Biotek is ₹16.44 Crs as of Sep-25.
This is greater than Mar-24 when it was ₹13.99 Crs.

The profit is oscillating.
The profit of Transgene Biotek is -₹1.62 Crs for TTM, -₹0.66 Crs for Mar 2024 and -₹6.01 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Transgene Biotek latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech